Choosing a PA-Free Product

With most herbs, choosing a bad product means wasting your money. With butterbur, choosing a bad product means swallowing hepatotoxic, DNA-damaging pyrrolizidine alkaloids twice a day for months. The plant is the same either way; what differs is whether a factory removed the alkaloids and whether a laboratory confirmed it.

This is the practical article. It covers what the trials actually used, what “PA-free” does and does not legally mean, how to ask for and read a certificate of analysis, the label red flags that should end the conversation, and the honest question of whether you should be buying this at all. Please read Pyrrolizidine Alkaloids and Liver Safety first — it explains why any of this matters.

Table of Contents

1. The Product Is the Medicine
2. The Two Extracts the Research Used
3. What “PA-Free” Legally Means
4. The Label Checklist
5. Red Flags That End the Conversation
6. How to Read a Certificate of Analysis
7. Five Questions to Email a Manufacturer
8. Availability, Cost and Why It Is Hard to Find
9. Building a Safe-as-Possible Regimen
10. When the Answer Is Simply “Don’t”
11. Key Research Papers
12. Connections

The Product Is the Medicine

Two capsules can both say “Butterbur, Petasites hybridus, 75 mg” and be entirely different substances. One might be a supercritical carbon-dioxide extract of the rhizome, standardised to a stated quantity of petasins, batch-tested for pyrrolizidine alkaloids down to the limit of detection. The other might be milled dried root, with no alkaloid testing at all, from a supplier who has never measured either compound class.

The first has clinical trials behind it. The second has the trials’ reputation behind it and the plant’s toxicology inside it. Nothing on the front of the bottle reliably tells them apart. This is not a niche concern about potency — the two products differ in whether they are safe.

Three things have to be true of a butterbur product before anything on the efficacy pages applies to it:

1. It is a standardised extract, with the petasin or petasine content stated as a number.
2. It has been tested for pyrrolizidine alkaloids, batch by batch, with results at or below the analytical limit of detection.
3. The manufacturer will show you the test results for the batch you are holding.

If any of the three is missing, you are not taking the thing that was studied. You are taking a plant with a known liver toxin in it.

The Two Extracts the Research Used

Essentially the entire clinical literature concerns two named preparations. Knowing which is which prevents a very common mistake — buying a migraine extract on the strength of allergy trials, or the reverse.

Two consequences follow. First, a US “butterbur for allergies” capsule is very often the root-type extract, sold on the reputation of leaf-extract trials. Second, because the migraine product’s regulatory history is complicated and its ownership and manufacturing have changed over the years, “it’s Petadolex” is not by itself a guarantee — you still want the current batch’s test data.

What “PA-Free” Legally Means

Less than you would hope, and it depends entirely on where you are.

In the United States, butterbur is a dietary supplement. Under the framework that governs supplements, a manufacturer does not need approval before selling, and no agency verifies the contents before the product reaches a shelf. “PA-free” on a US label is a manufacturer’s claim, not a certification by anyone independent. It can be entirely truthful and backed by rigorous testing. It can also be a phrase someone typed. Nothing about the label distinguishes those cases — only the test data does. The National Center for Complementary and Integrative Health advises that only products certified and labelled PA-free should be considered, which places the entire burden of verification on you.

In the European Union, maximum levels for pyrrolizidine alkaloids now apply to herbal infusions and to food supplements containing botanical ingredients, and Germany’s medicines regulator has applied strict daily ceilings — in the micrograms-per-day range — on internally used PA-containing medicinal products since the early 1990s, with a substantially lower ceiling for longer use. These are enforceable limits rather than voluntary claims, which is a meaningful difference. It is also why butterbur products in Europe are scarcer and more tightly controlled than in the United States.

In the United Kingdom, unlicensed butterbur products were withdrawn from sale after a 2012 regulatory warning about liver toxicity. If a UK-facing website is selling you butterbur, that history is worth knowing before you order.

There is one more thing “PA-free” does not mean, even when the testing is impeccable. It means below the limit of detection of the method used — not zero. A more sensitive instrument finds more. For a compound taken daily for months that damages DNA, that gap is not purely academic, and it is part of why regulators and guideline committees ended up uneasy despite the processing being genuinely good.

The Label Checklist

Work down this table with the bottle, or the product page, in front of you.

That last row is the single most informative line on the label. Any manufacturer who genuinely understands butterbur knows about the alkaloids and the liver. A label that carries no liver caution is evidence about the company, not about the plant.

Red Flags That End the Conversation

These are not “proceed with caution” signals. They are reasons to put the product down.

• Raw or cut butterbur root, rhizome, or dried leaf sold as a herb. No processing, no testing, full alkaloid load.
• Butterbur tea or tea bags. Water extracts the alkaloid N-oxides efficiently, and your gut converts them back to the parent alkaloids. This is close to the worst possible preparation.
• Tinctures, glycerites and home extracts. Alcohol does not selectively remove pyrrolizidine alkaloids.
• “Wildcrafted”, “wild-harvested”, “foraged”, “traditional whole-plant”. In most herbs these words signal care. Here they signal the absence of the industrial process that constitutes the entire safety margin.
• Marketplace listings with no manufacturer identity — unbranded capsules, white-label bottles, sellers who cannot be contacted.
• “Proprietary blend” containing butterbur at an undisclosed amount alongside six other herbs. You cannot dose it, and you cannot verify it.
• No petasin figure. If the useful compound is not quantified, nothing was standardised.
• No pyrrolizidine-alkaloid statement, or a refusal to supply a certificate of analysis on request.
• Marketing that leans on the Level A rating without mentioning that it was retired. A seller who omits that is either uninformed or being selective, and neither is what you want in the company whose testing is your only protection.
• Any suggestion that butterbur is safe in pregnancy, for children, or for long-term open-ended use. Flatly wrong, and disqualifying.

How to Read a Certificate of Analysis

A certificate of analysis (COA) is a laboratory report for a specific manufactured lot. Reputable supplement companies will send one if you ask, quoting the lot number from your bottle. It is not a difficult document to read once you know what you are looking for.

1. Does the lot number match your bottle? A COA for a different lot tells you about a different batch of plant material. This is the most common way a COA is used to reassure without informing.
2. Is there a pyrrolizidine-alkaloid line at all? Many COAs cover heavy metals, microbial counts and pesticides but never mention alkaloids. For butterbur, the alkaloid line is the point; the rest is routine.
3. What is the reported result, and in what units? You want a number with units — parts per million, micrograms per gram, or micrograms per daily dose — or an explicit “not detected” with the detection limit stated. “Not detected” without a detection limit is not a measurement.
4. What method was used? Modern analysis uses liquid chromatography coupled to mass spectrometry (LC-MS/MS or similar). Older, less sensitive methods will report “not detected” more easily and mean less by it.
5. Were N-oxides included? Good analyses measure the alkaloids and their N-oxides, because the gut converts N-oxides back into the parent compounds. A method that only looks for free alkaloids can miss a substantial share of the real exposure.
6. Who did the testing? An independent, named laboratory carries more weight than “tested in-house”.
7. Is the petasin content confirmed? The same document should verify that the useful compounds are present at the labelled amount.

If a company will not produce a COA for your lot, that is your answer. It is a routine document; declining to share it for a product with a known liver-toxin problem tells you what you need to know.

Five Questions to Email a Manufacturer

Copy these. A good company answers all five within a few days, in specifics.

1. “Please send the certificate of analysis for lot number [X], including the pyrrolizidine-alkaloid result.”
2. “What analytical method do you use for pyrrolizidine alkaloids, what is its limit of detection, and does it include the N-oxides?”
3. “Is every batch tested for pyrrolizidine alkaloids, or a sample of batches?”
4. “How many milligrams of petasins does each capsule contain?”
5. “Which laboratory performs the testing, and is it independent of your company?”

Vague answers — “our products are of the highest purity”, “we follow GMP”, “our supplier certifies it” — are non-answers. So is a marketing brochure. You asked for a number and a method; anything else is a decline.

Availability, Cost and Why It Is Hard to Find

If butterbur seems oddly hard to buy from a reputable source, that is not an accident — it is the regulatory history described above working as intended.

• United Kingdom: unlicensed products were withdrawn after the 2012 warning. Anything currently being sold into the UK deserves a hard look at where it comes from.
• Germany: the leading standardised extract lost its marketing authorisation over hepatic safety concerns, in the country where it was developed.
• United States: readily available as a supplement, with no pre-market verification of alkaloid content — the widest availability combined with the weakest guarantee.
• Cost: a properly tested standardised extract is not cheap. Four months at 75 mg twice daily is a meaningful outlay, and it buys, on the trial data, roughly two fewer migraine days a month. Generic magnesium and riboflavin cost a fraction of that with comparable evidence and no liver caveat.

It is worth sitting with the shape of that. When a herb is simultaneously restricted in the countries with the strictest medicines regulation and freely available in the country with the loosest supplement law, the difference reflects regulatory philosophy rather than any difference in the plant.

Building a Safe-as-Possible Regimen

If you have read all four articles, spoken to a clinician, and decided to proceed, this is the structure that keeps the risk as low as it can be made. It does not make butterbur safe; it makes it as safe as butterbur gets.

When the Answer Is Simply “Don’t”

Most of this website is written to help people use natural products well. This section is written to help you decide not to, because for butterbur that is often the right call.

Do not buy butterbur if:

• You cannot obtain a certificate of analysis with a pyrrolizidine-alkaloid result for your lot. This alone disqualifies most of what is for sale online.
• You have not yet tried the better-evidenced, lower-risk options — for migraine, magnesium, riboflavin, coenzyme Q10 and the modifiable triggers; for hay fever, saline rinses, intranasal corticosteroids and non-sedating antihistamines.
• You want it for a use with no evidence — asthma, general inflammation, “detox”, pain, coughs, anything drawn from the herb’s medieval reputation.
• You are unwilling or unable to have liver bloods monitored, or have no clinician you can tell.
• You would be taking it indefinitely. There is no long-term safety evidence, and the risk is cumulative.
• You are in any of the contraindicated groups.

Choosing not to take butterbur costs you very little. The trial data suggest a benefit of roughly two fewer migraine days a month at the effective dose, and magnesium or riboflavin can offer something comparable without asking you to trust a supply chain with your liver. That trade is available to almost everyone, and there is no shame in taking it. Butterbur is a real medicine trapped inside an unreliable market — and until the market is reliable, caution is not timidity, it is arithmetic.

Back to Table of Contents

Key Research Papers

Every identifier below was verified live against the NCBI PubMed database — title, first author, journal and year all had to match before publication here.

Measuring what is actually in a butterbur product

1. Avula B, Wang YH, Wang M, Smillie TJ, Khan IA. Simultaneous determination of sesquiterpenes and pyrrolizidine alkaloids from the rhizomes of Petasites hybridus (L.) G.M. et Sch. and dietary supplements using UPLC-UV and HPLC-TOF-MS methods. Journal of Pharmaceutical and Biomedical Analysis. 2012;70:53–63. Analytical methods applied to raw rhizome and to marketed dietary supplements — the work that turns “PA-free” from a claim into a measurable property.
2. Aydın AA, Letzel T. Simultaneous investigation of sesquiterpenes, pyrrolizidine alkaloids and N-oxides in butterbur (Petasites hybridus) with an offline 2D-combination of HPLC-UV and LC-MMI-ToF-MS. Journal of Pharmaceutical and Biomedical Analysis. 2013;85:74–82. Includes the N-oxides — the reason to ask whether a COA covered them.
3. Aydın AA, Zerbes V, Parlar H, Letzel T. The medical plant butterbur (Petasites): analytical and physiological (re)view. Journal of Pharmaceutical and Biomedical Analysis. 2013;75:220–229. Overview of the plant’s chemistry and the analytical challenge of separating the useful compounds from the harmful ones.
4. Kälin P. [The common butterbur (Petasites hybridus) — portrait of a medicinal herb.] Forschende Komplementärmedizin und Klassische Naturheilkunde. 2003;10(Suppl 1):41–44. German-language monograph on the plant and its preparations.

Why the testing matters: the safety literature

1. Anderson N, Borlak J. Hepatobiliary events in migraine therapy with herbs — the case of Petadolex, a Petasites hybridus extract. Journal of Clinical Medicine. 2019;8(5). The liver events reported with the standardised migraine extract, examined case by case.
2. Edgar JA, Molyneux RJ, Colegate SM. Pyrrolizidine alkaloids: potential role in the etiology of cancers, pulmonary hypertension, congenital anomalies, and liver disease. Chemical Research in Toxicology. 2015;28(1):4–20. Why low-level chronic exposure is treated as a genotoxic problem rather than a threshold one.
3. Moreira R, Pereira DM, Valentão P, Andrade PB. Pyrrolizidine alkaloids: chemistry, pharmacology, toxicology and food safety. International Journal of Molecular Sciences. 2018;19(6). Includes the food-supplement contamination route that drove the European maximum levels.
4. Neuman MG, Cohen L, Opris M, Nanau RM, Hyunjin J. Hepatotoxicity of pyrrolizidine alkaloids. Journal of Pharmacy & Pharmaceutical Sciences. 2015;18(4):825–843.

What the studied products achieved — the dose you are trying to match

1. Lipton RB, Göbel H, Einhäupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240–2244. Human randomised trial, 245 participants; 75 mg twice daily worked, 50 mg twice daily did not clearly separate from placebo — which is why the milligram figure on a label matters.
2. Schapowal A. Butterbur Ze339 for the treatment of intermittent allergic rhinitis: dose-dependent efficacy in a prospective, randomized, double-blind, placebo-controlled study. Archives of Otolaryngology–Head & Neck Surgery. 2004;130(12):1381–1386. Human randomised trial, 186 participants; a dose-response relationship for the leaf extract.
3. Sutherland A, Sweet BV. Butterbur: an alternative therapy for migraine prevention. American Journal of Health-System Pharmacy. 2010;67(9):705–711. A pharmacist’s-eye review emphasising product selection as the central safety issue.
4. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology. 2012;78(17):1346–1353. The Level A rating a seller may still be quoting at you — now carrying a [RETIRED] designation.

Live PubMed Searches

1. PA-free butterbur extract
2. PAs in dietary supplements
3. Herbal supplement quality and adulteration
4. Petasin standardisation methods
5. Supercritical CO₂ extraction of botanicals
6. PA N-oxide analysis by LC-MS
7. Petadolex
8. Ze 339 butterbur

Connections

• Butterbur Benefits — hub
• Pyrrolizidine Alkaloids and Liver Safety
• Migraine Prevention
• Allergic Rhinitis and Hay Fever
• Butterbur
• Comfrey — the same alkaloid problem
• Liver Function Tests
• GGT
• Magnesium — a lower-risk migraine option
• Vitamin B2 (Riboflavin)
• Stinging Nettle
• Feverfew
• Neurology
• Toxins
• All Herbs

Back to Table of Contents